Chargement en cours...
Evaluation of immunomodulatory drugs in multiple myeloma: single center experience
Objective: Multiple myeloma (MM) comprises 1% of all cancers and 10% of hematologic malignancies and known as an incurable disease. The introduction of immunomodulatory drugs (IMiDs) has brought a major shift in therapeutic paradigm in the treatment of newly diagnosed and relapsed/refractory MM pati...
Enregistré dans:
| Publié dans: | Am J Blood Res |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
e-Century Publishing Corporation
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4769352/ https://ncbi.nlm.nih.gov/pubmed/27069758 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|